Late diagnoses in upper GI cancer = poor outcomes.
This expert-led webcast breaks down how biomarker testing + guideline-based care can change the story.
📲 Watch now: https://t.co/f1KO3ksC6z
@KlempnerSam@Sam_Cytryn#GIcancer#OncologyCME#ImmunoOncology
Understanding ADC safety profiles and monitoring strategies is critical as these therapies expand in lung cancer care.
Learn practical insights for mNSCLC management.
👉 https://t.co/hxLUxAyrPp
#NSCLC#MedEd
🧠 Built for neuro-oncology, surgery, radiation oncology, advanced practice & nursing teams.
🔗 https://t.co/PveWnYv6bs
#NeuroOncologyEducation#MedEd
📋 Case-based learning brings VHL diagnosis & management to life with real-world scenarios.
🔗 https://t.co/wHF0LUERkw
#CaseBasedLearning#ClinicalEducation
Managing treatment-related toxicities is critical for continuity of care in EC.
Learn evidence-based approaches to improve patient safety.
👉 https://t.co/t0NfcDGMPl
#CancerCare#Oncology
🩺 Advanced imaging helps detect what PSA and biopsy may miss. Learn when and how to escalate diagnostics.
🔗 https://t.co/cMRpp7Dat7
#Radiology#ProstateCancer
WATCH NOW: Exploring the Horizons in Advanced or Recurrent Endometrial Cancer: Practical Considerations and FutureDirections for New Treatment Strategies. Download resources and collect credit: https://t.co/3xUa53oj4S https://t.co/Acl5UWgdwo
The future of upper GI cancer care is biomarker-driven.
Learn how to optimize treatment decisions with the latest evidence & multidisciplinary insights.
🎥 Watch + earn CME: https://t.co/f1KO3ksC6z
@KlempnerSam@Sam_Cytryn#CancerCME#GIoncology#BiomarkerTesting
Desmoid tumor management is evolving—are you up to date?
This CE equips nurses with the latest strategies in care.
📲 Watch on demand: https://t.co/gCBHRgTd9l
#OncologyNursing#CEConcepts#DesmoidTumors
WATCH NOW: A CaseWise™ Webcast: From Research to Real-World: ADCs, IO Combinations, and Sequencing in Metastatic NSCLC. Download resources and collect credit: https://t.co/5zuUzehOQM https://t.co/CnXeBDrrlj
🧑⚕️👩⚕️👨⚕️ Adoption works best with the full MDT—clinicians, nurses, pharmacists. Get strategies for subcutaneous ICI implementation.
🔗 https://t.co/jlCXykSzF6
#TeamBasedCare#OncologyNursing#Pharmacy
👩⚕️ Are you managing NF1-associated plexiform neurofibromas?
This activity delivers what you need to know about MEK inhibitors and building lifelong, individualized care plans.
📲 https://t.co/fIuH1b1rZZ
Community oncology faces unique challenges keeping up with RCC standards. Get practical guidance that fits real-world care.
Book a live or virtual Grand Round
🔗 https://t.co/8H6oukP9jz
#CommunityOncology#RCCCare